Affluent Medical governance and scientific advisory board brings together deep expertise in pathologies addressed and prior successful experiences in medtech companies.

“Affluent Medical is committed to offering the best available therapies worldwide for hitherto largely unmet needs in terms of widespread and critical diseases. Millions of patients around the world are suffering and cannot always find optimal therapies.

Affluent Medical focuses on breakthrough medical devices using a new approach. Deep understanding of the physiology helps us to design a new generation of minimally invasive prostheses with the aim of mimicking anatomy and restoring native physiology for critical functions.

Our approach heralds a new era for cardiovascular and urological therapies. The combination of our highly talented team and deep expertise will enable us to lead this major shift toward more physiological therapies.”

Vincent Gardès, Chairman.


Very large experience in the healthcare industry in both Europe and North America in listed companies. Formerly CEO of Theradiag, first CEO of Carmat, Deputy General Manager of Flamel Technologies, Senior Vice President of Aventis Group (now Sanofi). Board member and Vice President of France Biotech. Graduated from EM Lyon Business School (France), Certified Accountant.

Michel Finance

Chief Executive Officer

Extensive experience in developing and marketing high-tech and innovative medical devices, in the cardiovascular and surgical areas. Former VP of R&D of Sorin Cardiopulmonary. MBA INSEAD.


Chief Technology and Innovation Officer

Cardiac Surgeon, co-founder and former CEO at IMMR in Paris, Doctor in Medicine and faculty professor of thoracic and cardio-vascular surgery University Paris V.

François Laborde, MD, PhD

Chief Medical Officer

Experienced in leading financial activities for listed companies. Formerly deputy CFO at Vexim and audit manager at PwC. Graduated from ESCEM, degree in chartered accountancy (DEC), CPA.

Henri Lefebvre

Chief Financial Officer

Scientific Advisory board

Acknowledged father of modern mitral valve repair.
Co-founder of the Carmat artificial heart project.
Member of the Board of Directors of the World Heart Foundation.

Alain Carpentier, MD, Ph.D

Professor of Cardiac Surgery in Paris.

Cardiovascular Surgery, Baylor Health Care System in Dallas, USA. Chairman of the Heart Hospital Baylor Plano Research Institute.

Michael Mack, MD, FACC

Medical Director

Head of the Cardiovascular Surgery Department Echo-Lab at the Georges Pompidou European Hospital in Paris.

Alain Berrebi, MD

Interventional Echocardiographist

Head of the Urology Department at the Caremeau General Hospital in Nimes, France

Pierre Costa, MD

Professor of Urology

Professor of Cardiology

and Cardiothoracic Surgery, Lausanne. Routinely performs minimally invasive aortic and mitral valve surgery.

Piergiorgio Tozzi, MD

Professor of Cardiology

Professor of Cardiac Surgery, Nuremberg.

Routinely performs minimally invasive aortic and mitral valve surgery.

Theodor Fischlein, MD

Professor of Cardiac Surgery

Professor of Thoracic and Vascular Surgery and Cardiopulmonary Transplantation at Marie Lannelongue Hospital.

Dominique Fabre, MD

Professor of Thoracic and Vascular Surgery

Professor of Urology at Cochin Hospital, Paris.

Nicolas Barry Delongchamps, MD

Professor of Urology

Board of Directors


former CEO at Vexim, bought by Stryker in 2017.

Vincent Gardès


Former Global Head of Novartis Venture Fund, Co-founder & board member of Symetis.

Reinhard Ambros

Former Global Head of Novartis Venture Fund

Former COO Carmat, Former EADS, Matra.

Patrick Coulombier

Former COO Carmat

Professor of Internal Medicine, Fribourg.

Daniel Hayoz, MD

Professor of Internal Medicine,

Former CFO at Vexim, former ev3, Covidien.

José Da Gloria

Former CFO at Vexim

Former CEO of Europa Group, former President EMEA, St Jude Medical.

Thierry Herbreteau

Former CEO of Europa Group

Professor and Head of Cardiac Surgery, Georges Pompidou European Hospital, Paris.

Prof. Christian Latrémouille MD, PhD

Professor and Head of Cardiac Surgery

CEO of Marie Lannelongue Hospital, Paris, Former CEO of GE Healthcare Europe.

Jean-Michel Malbrancq

CEO of Marie Lannelongue Hospital

Founder & CEO of Truffle Capital, co-founder of Symetis, Vexim, Carmat.

Philippe Pouletty, MD

Founder & CEO of Truffle Capital